Cardiovascular software developer HeartFlow is touting decisions by Health Care Service Corp. (HCSC) and three Blue Cross/Blue Shield entities to cover the use of its fractional flow reserve (FFR) software.
The HeartFlow FFR-CT Analysis software is designed to help clinicians diagnose and treat patients with suspected coronary artery disease.
HCSC, which operates Blue Cross/Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma, and Texas, found that the use of noninvasive FFR following a positive coronary CT angiogram may be considered medically necessary to guide the treatment of patients with stable chest pain at intermediate risk of coronary artery disease.
In addition, Blue Cross/Blue Shield companies in Tennessee, Louisiana, and South Carolina recently issued a medical policy to cover use of the HeartFlow FFR Analysis software, HeartFlow said.
